Related references
Note: Only part of the references are listed.Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients
Jie Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Insulin Receptor Substrate 1/2 ( IRS1/2) Regulates Wnt/β-Catenin Signaling through Blocking Autophagic Degradation of Dishevelled2
Yongtao Geng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia
Luiza O. Perucci et al.
PLOS ONE (2014)
Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases
Zhen Zhao et al.
CLINICAL BIOCHEMISTRY (2013)
MicroRNAs in Human Placental Development and Pregnancy Complications
Guodong Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells
A. V. Sorokin et al.
ONCOGENE (2013)
Preeclampsia Up-Regulates Angiogenesis-Associated MicroRNA (i.e., miR-17,-20a, and-20b) That Target Ephrin-B2 and EPHB4 in Human Placenta
Wen Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The Art of MicroRNA Research
Eva van Rooij
CIRCULATION RESEARCH (2011)
Comment on: American Diabetes Association. Standards of medical care in diabetes-2011 (vol 34, pg e53, 2011)
V Basevi et al.
DIABETES CARE (2011)
The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes
R. I. G. Holt et al.
DIABETIC MEDICINE (2011)
Insulin receptor substrate 2 and FoxO3a signalling are involved in E-cadherin expression and transforming growth factor-β1-induced repression in kidney epithelial cells
Rosemarie M. Carew et al.
FEBS JOURNAL (2011)
MICRORNAS IN DEVELOPMENT AND DISEASE
Danish Sayed et al.
PHYSIOLOGICAL REVIEWS (2011)
MAPK and AP-1 proteins are increased in term pre-labour fetal membranes overlying the cervix: Regulation of enzymes involved in the degradation of fetal membranes
M. Lappas et al.
PLACENTA (2011)
Standards of Medical Care in Diabetes-2011 AMERICAN DIABETES ASSOCIATION
DIABETES CARE (2011)
Fat Cell-Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism
Anil Kumar et al.
DIABETES (2010)
Gestational diabetes mellitus screening based on the gene chip technique
Zhaoxia Liang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Preventing type 2 diabetes: public health implications for women with a history of gestational diabetes mellitus
Lucinda J. England et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Adipocytokines in Normal and Complicated Pregnancies
Despina D. Briana et al.
REPRODUCTIVE SCIENCES (2009)
Hyperglycemia and Adverse Pregnancy Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus
Boyd E. Metzger et al.
DIABETES CARE (2007)
Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice
R. Rao et al.
DIABETOLOGIA (2007)
Exercise training exacerbates tourniquet ischemia-induced decreases in GLUT4 expression and muscle atrophy in rats
Ying-Lan Tsai et al.
LIFE SCIENCES (2006)
Critical nodes in signalling pathways: insights into insulin action
CM Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats
A Nishiyama et al.
KIDNEY INTERNATIONAL (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)